<VariationArchive VariationID="13897" VariationName="NM_005378.6(MYCN):c.626dup (p.Ala210fs)" VariationType="Duplication" Accession="VCV000013897" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-06" DateCreated="2017-12-26" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28936" VariationID="13897">
      <GeneList>
        <Gene Symbol="MYCN" FullName="MYCN proto-oncogene, bHLH transcription factor" GeneID="4613" HGNC_ID="HGNC:7559" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="15940550" stop="15947004" display_start="15940550" display_stop="15947004" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="16080682" stop="16087128" display_start="16080682" display_stop="16087128" Strand="+" />
          </Location>
          <OMIM>164840</OMIM>
          <Haploinsufficiency last_evaluated="2017-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYCN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYCN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005378.6(MYCN):c.626dup (p.Ala210fs)</Name>
      <CanonicalSPDI>NC_000002.12:15942686:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="15942686" stop="15942687" display_start="15942686" display_stop="15942687" variantLength="1" positionVCF="15942686" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="16082808" stop="16082809" display_start="16082808" display_stop="16082809" variantLength="1" positionVCF="16082808" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>A210fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005378.5" sequenceAccession="NM_005378" sequenceVersion="5" change="c.626dupC">
            <Expression>NM_005378.5:c.626dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005378.4" sequenceAccession="NM_005378" sequenceVersion="4" change="c.626dup">
            <Expression>NM_005378.4:c.626dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.16082812dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.16082812dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.15942690dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.15942690dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007457.1" sequenceAccession="NG_007457" sequenceVersion="1" change="g.7130dup">
            <Expression>NG_007457.1:g.7130dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293228.2" sequenceAccession="NM_001293228" sequenceVersion="2" change="c.626dup">
            <Expression>NM_001293228.2:c.626dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280157.1" sequenceAccession="NP_001280157" sequenceVersion="1" change="p.Ala210fs">
            <Expression>NP_001280157.1:p.Ala210fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293233.2" sequenceAccession="NM_001293233" sequenceVersion="2" change="c.*561dup">
            <Expression>NM_001293233.2:c.*561dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005378.6" sequenceAccession="NM_005378" sequenceVersion="6" change="c.626dup" MANESelect="true">
            <Expression>NM_005378.6:c.626dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005369.2" sequenceAccession="NP_005369" sequenceVersion="2" change="p.Ala210fs">
            <Expression>NP_005369.2:p.Ala210fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293231.2" sequenceAccession="NM_001293231" sequenceVersion="2" change="c.157+1947dup">
            <Expression>NM_001293231.2:c.157+1947dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="164840.0005" DB="OMIM" />
        <XRef Type="rs" ID="1558534266" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005378.6(MYCN):c.626dup (p.Ala210fs) AND Feingold syndrome type 1" Accession="RCV000014911" Version="28">
        <ClassifiedConditionList TraitSetID="3836">
          <ClassifiedCondition DB="MedGen" ID="C4551774">Feingold syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005378.6(MYCN):c.626dup (p.Ala210fs) AND not provided" Accession="RCV003228894" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-26" MostRecentSubmission="2024-03-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18671284</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3836" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Oculodigitoesophagoduodenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Feingold syndrome type 1</ElementValue>
                <XRef ID="MONDO:0008115" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microcephaly-oculo-digito-esophageal-duodenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Digital anomalies with short palpebral fissures and atresia of esophagus, or duodenum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MICROCEPHALY, MENTAL RETARDATION, AND TRACHEOESOPHAGEAL FISTULA SYNDROME</ElementValue>
                <XRef Type="MIM" ID="164280" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MICROCEPHALY AND DIGITAL ABNORMALITIES WITH NORMAL INTELLIGENCE</ElementValue>
                <XRef Type="MIM" ID="164280" DB="OMIM" />
                <XRef Type="MIM" ID="602585" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FGLDS1</ElementValue>
                <XRef Type="MIM" ID="164280" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Feingold syndrome 1 (referred to as FS1 in this GeneReview) is characterized by digital anomalies (shortening of the 2nd and 5th middle phalanx of the hand, clinodactyly of the 5th finger, syndactyly of toes 2-3 and/or 4-5, thumb hypoplasia), microcephaly, facial dysmorphism (short palpebral fissures and micrognathia), gastrointestinal atresias (primarily esophageal and/or duodenal), and mild-to-moderate learning disability.</Attribute>
                <XRef ID="NBK7050" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17624" />
                <XRef ID="17624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301770</ID>
                <ID Source="BookShelf">NBK7050</ID>
              </Citation>
              <XRef ID="1305" DB="Orphanet" />
              <XRef ID="391641" DB="Orphanet" />
              <XRef ID="C4551774" DB="MedGen" />
              <XRef ID="MONDO:0008115" DB="MONDO" />
              <XRef Type="MIM" ID="164280" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7339545" SubmissionDate="2023-05-24" DateLastUpdated="2023-05-27" DateCreated="2023-05-27">
        <ClinVarSubmissionID localKey="GDXSV:272582" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003926186" DateUpdated="2023-05-27" DateCreated="2023-05-27" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 255 amino acids are replaced with 55 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18671284)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYCN" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:730968</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005378.4:c.626dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_192_20230524054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="35167" SubmissionDate="2017-12-22" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="164840.0005_FEINGOLD SYNDROME 1" title="MYCN, 1-BP DUP, 626C_FEINGOLD SYNDROME 1" />
        <ClinVarAccession Accession="SCV000035167" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Turkish girl with Feingold syndrome (FGLDS1; 164280), Blaumeiser et al. (2008) identified a de novo heterozygous 1-bp duplication (626dupC) in exon 2 of the MYCN gene, predicted to result in premature termination and nonsense-mediated mRNA decay of the exon 2-3 transcript. Neither unaffected parent carried the mutation. The girl had dysmorphic facial features, developmental delay, and distal limb anomalies. Blaumeiser et al. (2008) noted that finding a mutation in exon 2 of the MYCN gene indicated that the MYCN transcript containing exon 2 is necessary for normal development.</Attribute>
              <Citation>
                <ID Source="PubMed">18671284</ID>
              </Citation>
              <XRef DB="OMIM" ID="164280" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYCN" />
          </GeneList>
          <Name>MYCN, 1-BP DUP, 626C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 626C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="164840.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FEINGOLD SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35167" TraitType="Disease" MappingType="Name" MappingValue="FEINGOLD SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C4551774" Name="Feingold syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7339545" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

